Neoproteomics

Neoproteomics is a privately held proteomics and diagnostics company founded in 2006 and headquartered in the Boston area, with an additional presence in Moreland Hills, Ohio. The company operates as a specialized service provider and technology developer, utilizing advanced proteomic techniques to support research and diagnostic applications. Its business model appears to be service-oriented with platform development elements, catering to the growing demand for precision protein analysis in both academic and biopharmaceutical sectors. As a long-established private entity, it is likely revenue-generating through its contract services and collaborative projects.

Advanced proteomic analysis platform utilizing mass spectrometry, liquid chromatography, and bioinformatics for protein characterization, quantification, and biomarker discovery.

Neoproteomics competes in the fragmented contract proteomics services market against large, diversified CROs (e.g., Charles River, LabCorp), specialized proteomics service providers, and well-equipped academic core facilities. Differentiation is achieved through niche expertise, customized service, and deep analytical experience rather than scale.